The company makes portable testing kits which can be used in remote locations to detect the likes of HIV, Ebola and Zika
News

Limerick medtech firm Altratech has secured €3 million EU funding under the Horizon 2020 programme along with raising an additional €2.2 million from investors. The fundraising was led by Bank of Ireland’s Kernel Capital Growth Fund and Infinity Capital.

Altratech are developing a portable battery-operated 1-hour viral RNA detection kit. This enables rapid diagnosis and decision-making, on-site, in-clinic, nurses, clinicians, veterinarians, and eliminates the delays of waiting for lab RT-PCR results.

These kits allow accurate on-site detection of HIV, Ebola, Zika viruses, in remote settings with little or no infrastructure.

Altratech was founded by Tim Cummins and Brian O’Farrell in 2013.

http://www.engineersjournal.ie/wp-content/uploads/2017/06/blood-sample-1024x580.pnghttp://www.engineersjournal.ie/wp-content/uploads/2017/06/blood-sample-300x300.pngJames HarringtonNewsLimerick,medtech
Limerick medtech firm Altratech has secured €3 million EU funding under the Horizon 2020 programme along with raising an additional €2.2 million from investors. The fundraising was led by Bank of Ireland's Kernel Capital Growth Fund and Infinity Capital. Altratech are developing a portable battery-operated 1-hour viral RNA detection kit....